Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pulido

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Science of the Total Environment|February 3, 2023
Integrating stakeholders' inputs to co-design climate resilience adaptation measures in Mediterranean areas with conflicts between wetland conservation and intensive agricultureDavid Pulido-Velazquez, Leticia Baena-Ruiz, Beatriz Mayor, et al.
Nature Communications|February 18, 2022
Heterotypic interactions drive antibody synergy against a malaria vaccine candidateRobert J Ragotte, David Pulido, Amelia M Lias, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
ACS Central Science|May 31, 2021
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 VaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
The Journal of Clinical Investigation|February 9, 2022
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2Elena Mitsi, Jesús Reiné, Britta C Urban, et al.
Cell|June 18, 2019
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesDaniel G W Alanine, Doris Quinkert, Rasika Kumarasingha, et al.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
Cell Reports. Medicine|July 17, 2024
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodiesLloyd D W King, David Pulido, Jordan R Barrett, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Science of the Total Environment|February 3, 2023
Integrating stakeholders' inputs to co-design climate resilience adaptation measures in Mediterranean areas with conflicts between wetland conservation and intensive agricultureDavid Pulido-Velazquez, Leticia Baena-Ruiz, Beatriz Mayor, et al.
Nature Communications|February 18, 2022
Heterotypic interactions drive antibody synergy against a malaria vaccine candidateRobert J Ragotte, David Pulido, Amelia M Lias, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
ACS Central Science|May 31, 2021
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 VaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
The Journal of Clinical Investigation|February 9, 2022
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2Elena Mitsi, Jesús Reiné, Britta C Urban, et al.
Cell|June 18, 2019
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesDaniel G W Alanine, Doris Quinkert, Rasika Kumarasingha, et al.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
Cell Reports. Medicine|July 17, 2024
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodiesLloyd D W King, David Pulido, Jordan R Barrett, et al.
Pageof 5